100% de satisfacción garantizada Inmediatamente disponible después del pago Tanto en línea como en PDF No estas atado a nada 4,6 TrustPilot
logo-home
Examen

TEST BANK LEHNE'S PHARMACOLOGY FOR NURSING CARE, 10TH EDITION BY JACQUELINE BURCHUM, LAURA ROSENTHAL CHAPTER 1 110|COMPLETE GUIDE A+

Puntuación
-
Vendido
-
Páginas
241
Grado
A+
Subido en
13-06-2025
Escrito en
2024/2025

TEST BANK LEHNE'S PHARMACOLOGY FOR NURSING CARE, 10TH EDITION BY JACQUELINE BURCHUM, LAURA ROSENTHAL CHAPTER 1 110|COMPLETE GUIDE A+ Downloaded by: micmartinez55 | Distribution of this document is illegal S - The Marketplace to Buy and Sell your Study Material Chapter 01: Orientation to Pharmacology Burchum: Lehne’s Pharmacology for Nursing Care, 10th Edition MULTIPLE CHOICE 1. The nurse is teaching a patient how a medication works to treat an illness. To do this, the nurse will rely on knowledge of which topic? a. Clinical pharmacology b. Drug efficacy c. Pharmacokinetics d. Pharmacotherapeutics ANS: D Pharmacotherapeutics is the study of the use of drugs to diagnose, treat, and prevent conditions. Clinical pharmacology is concerned with all aspects of drug-human interactions. Drug efficacy measures the extent to which a given drug causes an intended effect. Pharmacokinetics is the study of the impact of the body on a drug. 2. What is a desired outcome when a drug is described as easy to administer? a. It can be stored indefinitely without need for refrigeration. b. It does not interact significantly with other medications. c. It enhances patient adherence to the drug regimen. d. It is usually relatively inexpensive to produce. ANS: C A major benefit of drugs that are easy to administer is that patients taking them are more likely to comply with the drug regimen. Drugs that are easy to give may have the other attributes listed, but those properties are independent of ease of administration. 3. A patient tells the nurse that an analgesic he will begin taking may cause drowsiness and will decrease pain up to 4 hours at a time. Based on this understanding of the drug’s effects by the patient, the nurse will anticipate which outcome? a. Decreased chance of having a placebo effect b. Decreased motivation to take the drug c. Improved compliance with the drug regimen

Mostrar más Leer menos
Institución
Pharm
Grado
Pharm











Ups! No podemos cargar tu documento ahora. Inténtalo de nuevo o contacta con soporte.

Libro relacionado

Escuela, estudio y materia

Institución
Pharm
Grado
Pharm

Información del documento

Subido en
13 de junio de 2025
Número de páginas
241
Escrito en
2024/2025
Tipo
Examen
Contiene
Preguntas y respuestas

Temas

Vista previa del contenido

 !"#
$!
%&

'$ () *+#+,-
.+(!/(
0!,* (
1
23
$
00
0+!-
4 *5/
#0!

/(*$/)1# /( 
(+

!
$ #
*$ '

(26
223*+)'#


,/00

8
7 
8
 01234156769   537  537 541 
0913161 7344754

,# 0123456789 515718250820125145




$%&'()*+,-.+/*0)1(&(021+(2+3%&*4&526278+
9:*5%:4.+;<=><?@+3%&*4&526278+A2*+B:*C017+$&*)D+-,(%+EF0(021+
+
GHIJK3IE+$L/K$E+
+
MN OPQ#RSTUQ#VU#WQXYPVRZ#X#[XWVQRW#P\]#X#^Q_VYXWV\R#]\T`U#W\#WTQXW#XR#VaaRQUUN#O\#_\#WPVUb#WPQ#RSTUQ#
]Vaa#TQac#\R#̀R\]aQ_ZQ#\d#]PVYP#W\[VYe#
XN faVRVYXa#[PXT^XY\a\Zc#
gN hTSZ#QddVYXYc#
YN iPXT^XY\`VRQWVYU#
_N iPXT^XY\WPQTX[QSWVYU#
jklm#h#
iPXT^XY\WPQTX[QSWVYU#VU#WPQ#UWS_c#\d#WPQ#SUQ#\d#_TSZU#W\#_VXZR\UQb#WTQXWb#XR_#[TQnQRW#Y\R_VWV\RUN#
faVRVYXa#[PXT^XY\a\Zc#VU#Y\RYQTRQ_#]VWP#Xaa#XU[QYWU#\d#_TSZoPS^XR#VRWQTXYWV\RUN#hTSZ#QddVYXYc#
^QXUSTQU#WPQ#QpWQRW#W\#]PVYP#X#ZVnQR#_TSZ#YXSUQU#XR#VRWQR_Q_#QddQYWN#iPXT^XY\`VRQWVYU#VU#WPQ#
UWS_c#\d#WPQ#V^[XYW#\d#WPQ#g\_c#\R#X#_TSZN#
qN rPXW#VU#X#_QUVTQ_#\SWY\^Q#]PQR#X#_TSZ#VU#_QUYTVgQ_#XU#QXUc#W\#X_^VRVUWQTe#
XN sW#YXR#gQ#UW\TQ_#VR_QdVRVWQac#]VWP\SW#RQQ_#d\T#TQdTVZQTXWV\RN#
gN sW#_\QU#R\W#VRWQTXYW#UVZRVdVYXRWac#]VWP#\WPQT#^Q_VYXWV\RUN#
YN sW#QRPXRYQU#[XWVQRW#X_PQTQRYQ#W\#WPQ#_TSZ#TQZV^QRN#
_N sW#VU#SUSXaac#TQaXWVnQac#VRQp[QRUVnQ#W\#[T\_SYQN#
jklm#f#
j#^Xt\T#gQRQdVW#\d#_TSZU#WPXW#XTQ#QXUc#W\#X_^VRVUWQT#VU#WPXW#[XWVQRWU#WX`VRZ#WPQ^#XTQ#^\TQ#aV̀Qac#W\#
Y\^[ac#]VWP#WPQ#_TSZ#TQZV^QRN#hTSZU#WPXW#XTQ#QXUc#W\#ZVnQ#^Xc#PXnQ#WPQ#\WPQT#XWWTVgSWQU#aVUWQ_b#
gSW#WP\UQ#[T\[QTWVQU#XTQ#VR_Q[QR_QRW#\d#QXUQ#\d#X_^VRVUWTXWV\RN#
uN j#[XWVQRW#WQaaU#WPQ#RSTUQ#WPXW#XR#XRXaZQUVY#PQ#]Vaa#gQZVR#WX`VRZ#^Xc#YXSUQ#_T\]UVRQUU#XR_#]Vaa#
_QYTQXUQ#[XVR#S[#W\#v#P\STU#XW#X#WV^QN#wXUQ_#\R#WPVU#SR_QTUWXR_VRZ#\d#WPQ#xyz{|}#QddQYWU#gc#WPQ#
[XWVQRWb#WPQ#RSTUQ#]Vaa#XRWVYV[XWQ#]PVYP#\SWY\^Qe#
XN hQYTQXUQ_#YPXRYQ#\d#PXnVRZ#X#[aXYQg\#QddQYW#
gN hQYTQXUQ_#^\WVnXWV\R#W\#WX`Q#WPQ#_TSZ#
YN s^[T\nQ_#Y\^[aVXRYQ#]VWP#WPQ#_TSZ#TQZV^QR#
_N sRYTQXUQ_#aV̀QaVP\\_#\d#_TSZ#\nQT_\UQ#
jklm#f#
j#_TSZ#VU#QddQYWVnQ#Vd#VW#[T\_SYQU#WPQ#VRWQR_Q_#QddQYWUb#QnQR#Vd#VW#XaU\#[T\_SYQU#UV_Q#QddQYWUN#
iXWVQRWU#]P\#SR_QTUWXR_#g\WP#WPQ#TVU`U#XR_#gQRQdVWU#\d#WX`VRZ#X#^Q_VYXWV\R#XTQ#^\TQ#aV̀Qac#W\#
Y\^[ac#]VWP#WPQ#_TSZ#TQZV^QRN#
#
GHIJK3IE+~E3/BE+
vN rPXW#XTQ#WPQ#[T\[QTWVQU#\d#XR#V_QXa#_TSZe#€‚ƒ‚„†‡ƒƒ†ˆ‡†‡‰‰ƒŠ‹Œ†
XN sTTQnQTUVgaQ#XYWV\R#




# 8859479514



9479514


9546789
4!1421488"14!872914!4 5

,# 0123456789 515718250820125145


#
$% &'()*+,-$*.*,/#
+% 0-1(#23#-)4*5*1,'-,*25#
)% 67(4*+-.#1,-$*.*,/#
(% 8#'(+295*:-$.(#,'-)(#5-4(#
8;<=#>?#6?#@#
A5#-))*,*25#,2#B'()*+,-$*.*,/?#(-1(#23#-)4*5*1,'-,*25?#-5)#+7(4*+-.#1,-$*.*,/?#2,7('#B'2B(',*(1#
*5+.C)(#-#'(D('1*$.(#-+,*25#12#,7-,#-5/#7-'4#,7(#)'C9#4-/#+-C1(#+-5#$(#C5)25(#-5)#-#1*4B.(#
9(5('*+#5-4(?#$(+-C1(#9(5('*+#5-4(1#-'(#C1C-../#+24B.(E#-5)#)*33*+C.,#,2#'(4(4$('#-5)#
B'252C5+(%#
F% >(32'(#-)4*5*1,('*59#-#4()*+-,*25?#G7-,#)2(1#,7(#5C'1(#5(()#,2#H52G#,2#(D-.C-,(#72G#*5)*D*)C-.#
IJKLMNKOPJQLJRLSLKTOULVWKOJXXMYKOKWMOIJKLMNKZ[OQM[I\N[MOK\OKWMOUM]LYJKL\N^O_`abacdefbbedgfdefhhbijke
-% 67(4*+-.#1,-$*.*,/#23#,7(#4()*+-,*25#
$% 0-1(#23#-)4*5*1,'-,*25#
+% l-4*./#4()*+-.#7*1,2'/#
)% mJKLMNKZ[#-9(#
(% mJKLMNKZ[#)*-9521*1#
8;<=#6?#@?#0#
n7(#3-4*./#4()*+-.#7*1,2'/#+-5#*5)*+-,(#9(5(,*+#3-+,2'1#,7-,#4-/#-33(+,#-#IJKLMNKZ[#'(1B251(#,2#-#
UM]LYJKL\NoOmJKLMNK[O\XO]LXXMQMNKOJVM[OYJNOQM[I\N]O]LXXMQMNKSTOK\OUM]LYJKL\N[oOpWMOIJKLMNKZ[O
*..5(11#+-5#-33(+,#72G#)'C91#-'(#4(,-$2.*:()%#n7(#+7(4*+-.#1,-$*.*,/#23#,7(#4()*+-,*25#-5)#,7(#
(-1(#23#-)4*5*1,'-,*25#-'(#B'2B(',*(1#23#)'C91%#
qrstuvwxyz{x|tt}~su~€x€‚xƒrsw„s€}€†x~x‡ˆw‰~xƒwsu~vx
Šˆwrˆ„{x‹ŒŽŒxƒrsw„s€}€†x‚€wx‡ˆw‰~xqswv‘x’yurx“”~u~€x
x
•–—˜™ƒ—“xqš›™q“x
x
œ% 8#B-,*(5,#*1#C1*59#-#4(,('())21(#*57-.('#+25,-*5*59#-.$C,('2.#32'#-1,74-%#n7(#4()*+-,*25#.-$(.#
*51,'C+,1#,7(#B-,*(5,#,2#J]ULNL[KMQOžŸ#BC331#(D('/##72C'1#-1#5(()()#32'#+2C97*59#2'#¡WMM¢LNVo£O
n7(#B-,*(5,#'(B2',1#3((.*59#¤*,,('/#124(,*4(1#G7(5#,-H*59#,7(#4()*+-,*25?#-5)#7(#2'#17(#]\M[NZKO
XMMSOKWJKOKWMOUM]LYJKL\NOL[OJS¡JT[OMXXMYKLPMoO¥WLYWOJYKL\NOL[O\¦K[L]MOKWMON¦Q[MZ[O[Y\IMO\XO
B'-+,*+(§#
-% 81H*59#,7(#B-,*(5,#,2#)(4251,'-,(#,7(#C1(#23#,7(#*57-.('#
$% 811(11*59#,7(#IJKLMNKZ[#(EB21C'(#,2#,2$-++2#142H(#
+% 8C1+C.,-,*59#.C59#12C5)1#-5)#2$,-*5*59#D*,-.#1*951#
)% <C99(1,*59#,7-,#,7(#B-,*(5,#C1(#œ#BC33#,2#'()C+(#1*)(#(33(+,1#
8;<=#@#
A,#*1#52,#G*,7*5#,7(#N¦Q[MZ[#1+2B(#23#B'-+,*+(#,2#+7-59(#,7(#)21(#23#-#4()*+-,*25#G*,72C,#-5#2')('#
3'24#-#B'(1+'*$('%#81H*59#,7(#B-,*(5,#,2#)(4251,'-,(#*57-.('#C1(#7(.B1#,7(#5C'1(#,2#(D-.C-,(#,7(#
IJKLMNKZ[OJRLSLKTOK\OJ]ULNL[KMQOKWMOUM]LYJKL\NOIQ\IMQSTOJN]OL[OIJQKO\XOKWMON¦Q[MZ[OMPJS¦JKL\No#
811(11*59#,2$-++2#142H(#(EB21C'(#7(.B1#,7(#5C'1(#)(,('4*5(#G7(,7('#525)'C9#,7('-B*(1?#1C+7#-#
142H(#-D2*)-5+(?#+-5#$(#C1()#-1#-5#-)¤C5+,#,2#)'C9#,7('-B/%#&('32'4*59#-#B7/1*+-.#-11(114(5,#
WMSI[OKWMON¦Q[MOMPJS¦JKMOKWMOIJKLMNKZ[OQM[I\N[MOK\OKWMOUM]LYJKL\No#




# 8859479514



9479514


9546789
4!1421488"14!872914!4 5

, # 0123456789 515718250820125145


#
$% &#'()*('+,-*./+#'-*.+0*#.)#1+.02#3.)45-,2+3#5(6+#7.*5#-4+*-6.0('5+08593,(4(3(0+#:;(,*-1<#=(,#
'-.0%#>5+#'-*.+0*#-)?)#*5+#0@,)+#-1(@*#@).02#>9A+0(A#=(,#=+/+,%#B5.45#)*-*+6+0*#19#*5+#0@,)+#.)#
4(,,+4*C#
-% DEF#.)#0(*#)-=+#*(#*-?+#(/+,G*5+G4(@0*+,#3,@2)#7.*5#',+)4,.'*.(0#HIJKLMFKNOPQR#
1% DSMTKOU#*5+#*7(#6+3.4-*.(0)#*(2+*5+,#'()+)#-#,.)?#(=#3,@2#FNVKLKFWQR#
4% DSXIYI#-,+#0(#?0(70#3,@2#.0*+,-4*.(0)Z#)(#*5.)#7.AA#1+#PM[IQR#
3% DSW\ION\#-03#;(,*-1#-,+#3.==+,+0*#3,@2)Z#)(#*5+,+#.)#0(#,.)?#(=#N]IYJNPIQR#
&^_#̀a#
>9A+0(A#.)#*5+#*,-3+#0-6+#-03#-4+*-6.0('5+0#.)#*5+#2+0+,.4#0-6+#=(,#*5+#)-6+#6+3.4-*.(0%#b*#.)#
.6'(,*-0*#*(#*+-45#'-*.+0*)#*(#1+#-7-,+#(=#*5+#3.==+,+0*#0-6+)#=(,#*5+#)-6+#3,@2#*(#6.0.6.c+#*5+#
,.)?#(=#(/+,3()+%#d/+,G*5+G4(@0*+,#ed>fg#6+3.4-*.(0)#-03#',+)4,.'*.(0#6+3.4-*.(0)#6-9#1+#
*-?+0#*(2+*5+,#@0A+))#).20.=.4-0*#5-,6=@A#3,@2#.0*+,-4*.(0)#-,+#'()).1A+%#h/+0#*5(@25#0(#3,@2#
.0*+,-4*.(0)#-,+#-*#'A-9#.0#*5.)#4-)+Z#1(*5#3,@2)#4(0*-.0#-4+*-6.0('5+0Z#75.45#4(@A3#A+-3#*(#
*(i.4.*9%#
j% >5+#0@,)+#.)#',+'-,.02#*(#4-,+#=(,#-#'-*.+0*#75(#7.AA#1+#*-?.02#-0#-0*.59'+,*+0)./+#6+3.4-*.(0%#
B5.45#-4*.(0#19#*5+#0@,)+#.)#'-,*#(=#*5+#-))+))6+0*#)*+'#(=#*5+#0@,).02#',(4+))C#
-% &)?.02#*5+#',+)4,.1+,#=(,#-0#(,3+,#*(#6(0.*(,#)+,@6#3,@2#A+/+A)#
1% k(0.*(,.02#*5+#'-*.+0*#=(,#3,@2#.0*+,-4*.(0)#-=*+,#2./.02#*5+#6+3.4-*.(0#
4% l@+)*.(0.02#*5+#'-*.+0*#-1(@*#(/+,G*5+G4(@0*+,#6+3.4-*.(0)#
3% >-?.02#*5+#mMFKIOFnP#1A((3#',+))@,+#*5,(@25(@*#*5+#4(@,)+#(=#*,+-*6+0*#
&^_#̀f#
>5+#-))+))6+0*#'-,*#(=#*5+#0@,).02#',(4+))#.0/(A/+)#2-*5+,.02#.0=(,6-*.(0#1+=(,+#1+2.00.02#
*,+-*6+0*Z#-03#*5.)#.04A@3+)#-)?.02#-1(@*#(*5+,#6+3.4-*.(0)#*5+#'-*.+0*#6-9#1+#*-?.02%#
k(0.*(,.02#)+,@6#3,@2#A+/+A)Z#7-*45.02#=(,#3,@2#.0*+,-4*.(0)Z#-03#45+4?.02#/.*-A#).20)#-=*+,#
2./.02#*5+#6+3.4-*.(0#-,+#-AA#'-,*#(=#*5+#+/-A@-*.(0#'5-)+%#
o% &#'()*('+,-*./+#'-*.+0*#,+'(,*)#'-.0Z#75.45#*5+#'-*.+0*#,-*+)#-)#-0#p#(0#-#)4-A+#=,(6#q#*(#qr#eqr#
1+.02#*5+#6()*#+i*,+6+#'-.0g%#>5+#',+)4,.1+,#5-)#(,3+,+3#-4+*-6.0('5+0#:>9A+0(A<#str#62#ud#
+/+,9#s#5(@,)#uv^#'-.0%#B5-*#7.AA#*5+#0@,)+#3(C#
-% &)?#*5+#'-*.+0*#75-*#6+3.4-*.(0)#5-/+#5+A'+3#7.*5#'-.0#.0#*5+#'-)*%#
1% f(0*-4*#*5+#',(/.3+,#*(#,+w@+)*#-#3.==+,+0*#-0-A2+).4#6+3.4-*.(0%#
4% x./+#*5+#'-.0#6+3.4-*.(0#-03#,+'().*.(0#*5+#'-*.+0*#*(#',(6(*+#4(6=(,*%#
3% v+w@+)*#-0#(,3+,#*(#-36.0.)*+,#*5+#6+3.4-*.(0#+/+,9#o#5(@,)%#
&^_#̀a#
>5+#0@,).02#3.-20().)#=(,#*5.)#'-*.+0*#.)#)+/+,+#'-.0%#&4+*-6.0('5+0#.)#2./+0#=(,#6.A3#*(#
6(3+,-*+#'-.0Z#)(#*5+#0@,)+#)5(@A3#-)?#*5+#',+)4,.1+,#*(#(,3+,#-#)*,(02+,#-0-A2+).4#6+3.4-*.(0%#
&)?.02#*5+#'-*.+0*#*(#*+AA#*5+#0@,)+#75-*#5-)#5+A'+3#.0#*5+#'-)*#.)#'-,*#(=#-0#.0.*.-A#-))+))6+0*#-03#
)5(@A3#1+#3(0+#',+('+,-*./+A9#-03#0(*#75+0#*5+#'-*.+0*#.)#5-/.02#)+/+,+#'-.0%#a+4-@)+#*5+#
'-*.+0*#.)#5-/.02#)+/+,+#'-.0Z#-4+*-6.0('5+0#4(61.0+3#7.*5#0(03,@2#*5+,-'.+)#7.AA#0(*#1+#
)@==.4.+0*%#b04,+-).02#*5+#=,+w@+049#(=#*5+#3()+#(=#-#6+3.4-*.(0#=(,#6.A3#'-.0#7.AA#0(*#1+#
+==+4*./+%#
t% &#'-*.+0*#0+7A9#3.-20()+3#7.*5#3.-1+*+)#.)#*(#1+#3.)45-,2+3#=,(6#*5+#5()'.*-A%#>5+#0@,)+#
*+-45.02#*5.)#'-*.+0*#-1(@*#5(6+#6-0-2+6+0*#)5(@A3#1+2.0#19#3(.02#75-*C#



# 8859479514



9479514


9546789
4!1421488"14!872914!4 5
$8.49
Accede al documento completo:

100% de satisfacción garantizada
Inmediatamente disponible después del pago
Tanto en línea como en PDF
No estas atado a nada

Conoce al vendedor
Seller avatar
VERIFIEDPASS
5.0
(1)

Conoce al vendedor

Seller avatar
VERIFIEDPASS Chamberlain College Of Nursing
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
7
Miembro desde
8 meses
Número de seguidores
3
Documentos
1236
Última venta
14 horas hace
nursing

On this page, you find all documents, package deals, and flashcards offered by seller VERIFIEDPASS

5.0

1 reseñas

5
1
4
0
3
0
2
0
1
0

Recientemente visto por ti

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes